Anticancer and Antimicrobial Activities of Naproxen and Naproxen Derivatives

被引:38
作者
Han, M. Ihsan [1 ]
Kucukguzel, S. Guniz [2 ]
机构
[1] Erciyes Univ, Fac Pharm, Dept Pharmaceut Chem, TR-38030 Kayseri, Turkey
[2] Marmara Univ, Fac Pharm, Dept Pharmaceut Chem, TR-34854 Istanbul, Turkey
关键词
Naproxen; non-steroidal anti-inflammatory drug; side effect; anticancer; antimicrobial; COX-2; enzyme; NONSTEROIDAL ANTIINFLAMMATORY DRUGS; URINARY-BLADDER; CYCLOOXYGENASE INHIBITORS; COMPLEXES; APOPTOSIS; NSAIDS; CELLS; OXIDE; NUCLEOPROTEIN; PROLIFERATION;
D O I
10.2174/1389557520666200505124922
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
This review explains the effects of naproxen and the naproxen moiety in important biological activities. Naproxen, 2-(6-methoxynaphthalen-2-yl)propionic acid, is one of the most utilized propionic acid derivatives to the cure of many injuries or pains. Naproxen is a non-steroidal anti-inflammatory drug (NSAID), which is generally used among the NSAIDs. Even though it has gastrointestinal side effects, naproxen has been safely used for many years because of the good cardiovascular sight. In the past years, except for anti-inflammatory effects, other pharmacological activities of naproxen, especially anticancer and antimicrobial activities, gain the attention of researchers. Naproxen shows its activity by inhibiting the COX-2 enzyme. There is significant interest in the possibility that COX-2 inhibitors might retard or prevent the development of various cancer types, which is often characterized by COX-2 expression. The activities of both naproxen and new molecules derived from naproxen were frequently investigated.
引用
收藏
页码:1300 / 1310
页数:11
相关论文
共 69 条
  • [1] Pharmacokinetic studies of naproxen amides of some amino acid esters with promising colorectal cancer chemopreventive activity
    Aboul-Fadl, Tarek
    Al-Hamad, Soliman S.
    Fouad, Ehab A.
    [J]. BIOORGANIC CHEMISTRY, 2018, 76 : 370 - 379
  • [2] Novel non-cyclooxygenase inhibitory derivatives of naproxen for colorectal cancer chemoprevention
    Aboul-Fadl, Tarek
    Al-Hamad, Suliman S.
    Lee, Kevin
    Li, Nan
    Gary, Bernard D.
    Keeton, Adam B.
    Piazza, Gary A.
    Abdel-Hamid, Mohammed K.
    [J]. MEDICINAL CHEMISTRY RESEARCH, 2014, 23 (09) : 4177 - 4188
  • [3] Synthesis, characterization and biological activity of new mixed ligand complexes of Zn(II) naproxen with nitrogen based ligands
    Abu Ali, Hijazi
    Fares, Hadeel
    Darawsheh, Mohanad
    Rappocciolo, Emilia
    Akkawi, Mutaz
    Jaber, Suhair
    [J]. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2015, 89 : 67 - 76
  • [4] Discovery of (R)-2-(6-Methoxynaphthalen-2-yl)butanoic Acid as a Potent and Selective Aldo-keto Reductase 1C3 Inhibitor
    Adeniji, Adegoke
    Uddin, Md. Jashim
    Zang, Tianzhu
    Tamae, Daniel
    Wangtrakuldee, Phumvadee
    Marnett, Lawrence J.
    Penning, Trevor M.
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2016, 59 (16) : 7431 - 7444
  • [5] AL-Janabi AAHS, 2011, IRAN J PHARM RES, V10, P547
  • [6] Synthesis of terpolymer-lipid encapsulated diruthenium(II,III)-anti-inflammatory metallodrug nanoparticles to enhance activity against glioblastoma cancer cells
    Alves, Samara Rodrigues
    Colquhoun, Alison
    Wu, Xiao Yu
    Silva, Denise de Oliveira
    [J]. JOURNAL OF INORGANIC BIOCHEMISTRY, 2020, 205
  • [7] Naproxen derivatives: Synthesis, reactions, and biological applications
    Ammar, Y. A.
    Salem, M. A.
    Fayed, Eman A.
    Helal, M. H.
    El-Gaby, M. S. A.
    Thabet, H. Kh.
    [J]. SYNTHETIC COMMUNICATIONS, 2017, 47 (15) : 1341 - 1367
  • [8] Ammar Y.A., 2015, Am. J. Pharm. Tech. Res, V5, P245
  • [9] Clinical Pharmacology and Cardiovascular Safety of Naproxen
    Angiolillo, Dominick J.
    Weisman, Steven M.
    [J]. AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS, 2017, 17 (02) : 97 - 107
  • [10] Novel metallo-therapeutics of the NSAID naproxen. Interaction with intracellular components that leads the cells to apoptosis
    Banti, C. N.
    Giannoulis, A. D.
    Kourkoumelis, N.
    Owczarzak, A. M.
    Kubicki, M.
    Hadjikakou, S. K.
    [J]. DALTON TRANSACTIONS, 2014, 43 (18) : 6848 - 6863